Biochemical markers and bone mineral density in patients with hip fractures in men

Endocrine Research

Volumn 26, Issue 2, 2000, Pages 275-288

  Ohishi, T ^a   Takahashi, M ^a   Kushida, K ^a   Omura, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; ESTRADIOL BLOOD LEVEL; GONAD FUNCTION; HIP FRACTURE; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 0033941486     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.3109/07435800009066167     Document Type: Article

References (28)

1. Riggs BL, Melton LJ. 1986 Medical progress series: Involutional osteoporosis. N Engl J Med 314: 1676-1686.
2. Seeman E, Melton III LJ, O'Fallon WM, Riggs BL. 1983 Risk factors for spinal osteoporosis in men. Am J Med 75: 977-983.
3. Garnero P, Hausherr E, Chapuy M-C, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD. 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 11: 1531-1538.
4. Melton III LJ, Khoslar S, Atkinson EJ, O'Fallon WM, Riggs BL. 1997 Relationship of bone turnover to bone density and fracture. J Bone Miner Res 12: 1083-1091.
5. Nydegger V, Rizzoli R, Rapin CH, Vasey H, Bonjour JPH. 1991 Epidemiology of fractures of the proximal femur in Geneva: Incidence, clinical and social aspect. Osteoporosis Int 2: 42-47.
6. Fisher ES, Baron JA, Malenka PJ, Barrett JA, Kniffin WD, Whaley FS, Bubolz TA. 1991 Hip fracture incidence and mortality in New England. Epidemiology 2: 116-122.
7. Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC 1989 Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci 86:854-857.
8. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF. 1987 Osteoporosis in men with hypogonadotropic hypogonadism. Ann Intern Med 106: 354-361.
9. Jackson JA, Kleerekoper M, Parfit AM. 1986 Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. Ann Int Med 105: 543-545.
10. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley WF. 1989 Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69: 776-783.
11. Rigotti NA, Neer RM, Jameson L. 1986 Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism. JAMA 256: 385-388.
12. Ohishi T, Koide Y, Takahashi M, Oikawa M, Kushida K 1999 A case of femoral neck fracture in a patient with severe testosterone deficiency. J Bone Miner Metab 17: 51-54.
13. Jackson JA, Riggs MW, Spiekerman AM. 1992 Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 304(1): 4-8.
14. Stanley HL, Schmitt BP, Poses RM, Deiss WP. 1991 Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? JAGS 39: 766-771.
15. Greenspan SL, Oppenheim DS, Klibanski A. 1989 Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110: 526-531.
16. Tenover JS. 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75: 1092-1098.
17. Anderson FH, Francis RM, Peaston RT, Wastell HJ. 1997 Androgen supplementation in eugonadal men with osteoporosis: effects of six months treatment on markers of bone formation and resorption. J Bone Miner Res 12: 472-478.
18. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC. 1997 Sex steroids and bone mass in older men - Positive associations with serum estrogens and negative associations with androgen. J Clin Invest 100: 1755-1759.
19. Rosenquist C, Qvist P, Bjarnason N, Cristiansen C 1995 Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 10: 1439-1445.
20. Takahashi M, Kushida Y, Hoshino H, Ohishi T, Inoue T. 1997 Investigation of the performance of ELI SA for N-terminal midfragment of osteocalcin. J Bone Miner Metab 15: 132-137.
21. Pratt DA, Daniloff Y, Duncan A, Robins SP. 1992 Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem 207: 163-175.
22. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. 1994 Immunoassay for quantifying type I collagen degradation products y in urine evaluated. Clin Chem 40: 2022-2025.
23. Bonde M, Qvist P, Fledelius Q Riis BJ, Christiansen C. 1995 Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 80: 864868.
24. Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C. 1997 Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 12: 1028-1034.
25. Orimo H, Sugioka Y, Hukunaga H, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, Oh-hashi Y. 1996 Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 4: 643-652.
26. Boonen S, Vanderschueren D, Cheng XG, Verbeke G, Dequeker J, Geusens P, Broos P, Bouillon R. 1997 Age-related (type II) femoral neck osteoporosis in men: Biochemical evidence for both hypovitaminosis D-and androgen deficiency-induced bone resorption. J Bone Miner Res 12: 2119-2126.
27. Takahashi M, Kushida K, Hoshino H, Ohishi T, Inoue T. 1997 Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption. J Endocrinol Invest 20: 112-117.
28. Ohishi T, Kushida K, Takahashi M, Hoshino H, Tsuchikawa T, Naitoh K, Inoue T. 1998 Changes of biochemical markers during fracture healing. Arch Orthop Trauma Surg 118: 126-130.